top of page

CAN MEN GET PREGNANT? : ABORTION DOCTOR REFUSED TO ANSWER A YES OR NO

  • Writer: Cydi Godzn
    Cydi Godzn
  • Jan 15
  • 2 min read

Can men get pregnant? The Awkward moment, Abortion Doctor refused to answer the question.


On January 15, 2026, a significant moment unfolded in Congress when a medical doctor chose not to answer whether men can become pregnant. This five-minute debate took place during a hearing focused on the abortion pill, organized by the U.S. Senate Committee on Health, Education, Labor, and Pensions, titled "Protecting Women: Exposing the Dangers of Chemical Abortion Drugs."

The exchange featured Republican Senator Josh Hawley of Missouri and Dr. Nisha Verma, an abortion doctor with Physicians for Reproductive Health based in Atlanta, Georgia. Dr. Verma testified about the safety of the abortion drug mifepristone, yet her credibility faced scrutiny when she could not address the question of men’s ability to become pregnant.


"Can men get pregnant? You're a doctor, I believe," Hawley pressed.


"Science and evidence should guide medicine," Dr. Verma replied.


"Do science and evidence indicate that biological men can get pregnant? Can they get pregnant?" questioned Hawley.


"I also believe that yes-no questions like this are a political tool," Verma protested.


"No," Hawley responded with conviction. "Yes-no questions are about the truth, doctor. Let’s keep this proceeding respectful."


Another physician who testified delivered a counterpoint to Dr. Verma's assertions. Dr. Monique Wubbenhost, an obstetrician-gynecologist, spoke about the potential risks of mifepristone, highlighting harm to women, particularly when acquired through the mail.


"The different risks associated with it include bleeding, infection, hemorrhage, the need for transfusion, and perforation," she noted.


Louisiana Attorney General Elizabeth Murrill informed the committee that obtaining the drug via mail is alarmingly simple, evading abortion bans in her state and about a dozen others.


"Following the Dobbs decision, the Biden FDA announced the removal of in-person dispensing requirements for abortion pills, enabling mifepristone to be shipped nationwide by mail," she explained.


Witnesses shared powerful stories of profound struggles, revealing how fathers, traffickers, and even family members wrongfully acquired the drug through dubious means, forcing women to take it against their will or administering it secretly.


After the hearing, pro-life leaders, led by Tony Perkins, president of the Family Research Council, held a news conference, passionately calling for the Trump administration to halt the distribution of the abortion drug until its risks can be comprehensively evaluated. They believe in the critical importance of prioritizing the safety of the unborn. Pro-life advocates are urging the FDA to reinstate mandatory in-person visits for patients seeking the drug.


"The time for bureaucratic delay is over," Perkins asserted. "It’s time to honor the rights of states to protect the unborn. Every voice matters, and the American public can make their opinions known by texting 'LIFE' to 67742 and signing the petition urging the FDA to take decisive action."


Perkins recognized that the FDA's commitment to reviewing mifepristone is commendable but emphasized the need for urgency, noting that the review has "dragged on for months.”



Comments


bottom of page